Skip to main content
SpringerLink
Log in

Healthcare Reform in Europe

  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

The European welfare states are currently struggling with tremendous budget problems. Most debate appears to be concerned with how to cut healthcare costs. Unfortunately, limiting the state’s costs, rather than enhancing the people’s well-being, has become the prime focus of new healthcare strategies in the European welfare states. The result has been a reduction in the quality and availability of healthcare services and a diminishing contribution to medical innovation by most European countries.

Abandonment of the ‘pay-as-you-go’ financing system is the only solution to increasingly unsustainable welfare state healthcare systems. A system financed by a capitalisation mechanism would be protected from the increasing costs associated with demographic evolution, while providing all members of society with the opportunity for affordable healthcare coverage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rubenstein ES. Comparative spending of governments. The right data. New York: National Review Books, 1994

    Google Scholar 

  2. Van Overtveldt J. Spilzieke huisvader. Trends; 18 Jul 1994

    Google Scholar 

  3. Aging populations, pension systems and government budgets: how do they affect saving? OECD, 1995

  4. Europe’s recession prompts new look at welfare costs: benefits reduce new hiring. The New York Times; 7 Aug 1993

  5. Belgium. Health care in Europe: the finance and reimbursement systems of 18 European countries. Ch. 3. Zoetermeer, The Netherlands: Nationale Raad voor de Volksgezondheid, 1993

  6. The Reform of Health Care. OECD, 1992

  7. Van Overtveldt J. Dokters in management. Trends; 17 June 1993

    Google Scholar 

  8. Industry profile: pharmaceuticals. German brief. Frankfurter Allgemeine Zeitung Information Services; 5 Nov 1993

  9. Blendon RJ, Donelan K, Leitman R. Physicians’ perspectives on caring for patients in the United States, Canada, and West Germany. N Engl J Med 1993; 328(14): 1011–6

    Article  PubMed  CAS  Google Scholar 

  10. Le Grand J. The evaluation of health care system reforms. In: Ferrera M, editor. The evaluation of social policies: experiences and perspectives. Faculty of Political Science of the University of Pavia, 1993

    Google Scholar 

  11. Health Insurance in The Netherlands. The Hague: Ministry of Welfare, Health and Cultural Affairs, 1992

  12. Schöffski O. Consequences of implementing a drug budget for office-based physicians in Germany. PharmacoEconomics 1996; 10 Suppl. 2: 37–47

    Article  PubMed  Google Scholar 

  13. Münnich FE, Sullivan K. The impact of recent legislative change in Germany. PharmacoEconomics 1994; 6 Suppl. 1: 22–7

    Article  PubMed  Google Scholar 

  14. Der Spiegel. 11 Apr 1994

  15. Healthcare spending set to race ahead in Asia. The Financial Times; 27 Apr 1995

Download references

Author information

Authors and Affiliations

  1. Centre for the New Europe, Zellik, Belgium

    Paul Belien

Authors
  1. Paul Belien
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belien, P. Healthcare Reform in Europe. PharmacoEconomics 10 (Suppl 2), 94–99 (1996). https://doi.org/10.2165/00019053-199600102-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199600102-00015

Keywords

Search

Navigation